Surprisingly little is known about how resources are spent on US health care. Most government and academic research focuses on a single payer, age group, or set of health conditions. Reconciling how health care spending varies across health condition, age and sex group, type of care, and time can help health system researchers and policymakers identify the drivers of spending increases. Health burden can only be properly addressed if resources, technology, and innovation are allocated with an in-depth understanding of the current health spending landscape.
This brief presents findings for Zambia from the 2014 Gavi Full Country Evaluations (FCE) Annual Dissemination Report. It reflects content from the 2014 Annual Dissemination Report.
This report presents findings for Bangladesh from the 2015 Gavi Full Country Evaluations (FCE) Annual Dissemination Report.
Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritize investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate how disease burden changes with development.
Health care spending on children in the United States continues to rise, yet little is known about how this spending varies by condition, age and sex group, and type of care, nor how these patterns have changed over time.
Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and program decision-making. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures to monitor such changes in population health: disability-adjusted life years (DALYs) and healthy life expectancy (HALE). We used these measures to track trends and benchmark progress compared with expected trends on the basis of the Socio-demographic Index (SDI).
Global development goals increasingly rely on country-specific estimates for benchmarking a nation’s progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017.
Health forecasts and alternative future scenarios can influence long-term planning and investments. The study shows that people’s health can improve, but such improvement demands attention, resources, action, and continued prioritization of these drivers of health.
This policy report presents key findings from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) for the US and documents trends in nearly 300 different diseases and injuries that are killing people prematurely and disabling them. The report sheds light on the substantial health threat posed by potentially modifiable risk factors such as poor diet, high body mass index, and lack of physical activity. It also provides an in-depth look at life expectancy, obesity, and physical activity in US counties.
The United Kingdom has provided universal health care and public health programming for more than six decades. To guide future policymaking in the UK, it is important to analyze trends in population health over time. Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010), researchers examined three critical questions: what are the patterns of health loss in the UK, what are the leading preventable risks that explain some of those patterns, and how do UK outcomes compare to a set of comparable countries in the European Union (EU) and elsewhere in 1990 and 2010.
Australians live longer, healthier lives than people in almost every other country, but a range of ailments threatens advances made in recent years, a symposium on groundbreaking data at the University of Melbourne reveals.
Infectious diseases remain among the leading causes of death and disability worldwide. In today’s world, the infectious disease agents are dynamic, resilient, and capable of spreading across borders efficiently. New and old infectious diseases periodically emerge and re-emerg...
We use the Global Burden of Disease Study 2013 data on mortality and causes of death, and disease and injury incidence and prevalence to analyze the burden of disease and injury in England as a whole, in English regions, and within each English region by deprivation quintile. We also assess disease and injury burden in England attributable to potentially preventable risk factors. England and the English regions are compared with the remaining constituent countries of the UK and with comparable countries in the European Union (EU) and beyond.
This report presents findings for Mozambique from the 2015 Gavi Full Country Evaluations (FCE) Annual Dissemination Report.
The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context.
Explore US health care spending for 155 conditions for the years 1996 through 2013. Use the interactive Sankey diagram, treemap, and pyramid chart to analyze trends by age, sex, type of care, and condition. New in Nov 2017: view how different factors drove changes in spending.
As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.
The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an aging global population, and an expansion of the non-fatal burden of disease and injury. These studies have also shown how a substantial portion of the world’s population experiences non-fatal health loss with considerable heterogeneity among different causes, locations, ages, and sexes. Ongoing objectives of the GBD study include increasing the level of estimation detail, improving analytical strategies, and increasing the amount of high-quality data.
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. Learn more about the new findings.